Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
Alibaba Shares Fall as AI Spending Hits Profit 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
SK Hynix Shares Surge on Record $28.6 Billion Buyback 
Anthropic IPO Could Challenge SpaceX’s Record $86 Billion Offering 
Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
OpenAI Tightens AI Safety Monitoring After Security Incidents 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Add as a preferred source on Google
LOUISVILLE, Ky., Feb. 22, 2016 -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the Texas State Board of Pharmacy (TSBP) has signed an agreement to adopt Appriss' Prescription Drug Monitoring Solution, PMP AWARxE, to improve patient safety, combat prescription drug abuse and drug diversion.
Prescription Monitoring Programs (PMPs) are state-run programs that track the distribution of narcotics and other prescriptions for federally controlled substances. PMP AWARxE provides access to mandatory pharmacy reporting and offers secure accessibility to data across state lines.
"Appriss is proud to support the TSBP in the promotion of patient safety," said Krishnan Sastry, Executive Vice President of Appriss. "There is a definite evolution of focus of the prescription monitoring programs from solely being a vehicle for surveillance and law enforcement to one that helps identify patients at risk for opioid abuse and finding them the help they need. PMPs can serve as a core foundation in that mission to improve patient safety and fight addiction."
The TSBP will implement the HIPAA-compliant PMP platform in the fall of 2016 and joins 24 other states in adopting an Appriss prescription monitoring solution nationally.
About Appriss
Appriss provides data-driven solutions to fulfill our mission of keeping communities safe and informed. Partnering with public safety, healthcare, and leading private and public companies, Appriss delivers solutions that prevent fraud, mitigate risk, fight crime, ensure compliance, increase public safety and save lives. Appriss' solutions are always backed by excellent customer support with technical agents in the US that are available to help 24x7x365.
For more information, visit www.appriss.com (http://www.appriss.com).
CONTACT: Kathy Sue Bennett
Marketing Manager
Appriss, Inc.
[email protected]
